Phase 2 Neuroblastoma Recurrent Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
St. Jude Children's Research Hospital54 enrolled1 locationNCT07085338
Recruiting
Phase 2
Quadruple Immunotherapy for Neuroblastoma
Neuroblastoma Recurrent
Hong Kong Children's Hospital29 enrolled1 locationNCT05754684
Recruiting
Phase 2
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
NeuroblastomaNeuroblastoma Recurrent
Jakob Stenman24 enrolled5 locationsNCT04903899